Search Results

You searched for : gsk  

5 Worst enemies of a glowing skin and ways to deal with them

Glowing and flawless skin adds to your confidence level. We do not hesitate to spend money on expensive beauty products. But are you aware of ...
Dec 16

5 Foods for Glowing Skin - Medicircle

Our skin is the largest organ of the body. It gains its shine and health from what we eat. By eating these 5 foods, you ...
Oct 29

Coconut Water - The best health drink

Include coconut water into your life and see its benefits help you gain better skin, hair, low risk of kidney stones and more....
Oct 13

Sandoz completes acquisition of GSK’s cephalosporin business, reinforcing leading global position in antibiotics

Latest Pharma news update...
Oct 12

Face Skin problems solutions with home remedies

Every person's skin tone and other symptoms are different from another person and some people's skin needs more care than usual. Along with ...
Oct 06

7 vitamin A rich foods for glowing skin

Vitamin A can eliminate and fight against free radicals, which in turn protects your skin from ageing. ...
Oct 01

Sehat Ki Baat, Karishma Ke Saath- Episode 24 -Diet for Healthy ageing

Karishma Shah and Dr. Jolly Shah give their advice on healthy skin and hair. Some valuable tips in this interview will help you to defeat ...
Sep 13

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update...
Aug 02

GSK announces positive headline results from five Phase 3 studies of daprodustat for patients with anaemia

GSK plc today announced positive headline results from five studies of the Phase 3 ASCEND programme, for patients with anaemia due to chronic kidney disease (...
Jul 17

Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India

In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a ...
Jul 09

ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE drug delivery technology

Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ...
Jun 22

GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448

With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG....
Jun 14

GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19

GSK's Covid product could be soon in the market after the emergency medical application review...
May 11

FDA Approves GlaxoSmithKline's immunotherapy for Endometrial Cancer with specific biomarker

GSK gets FDA nod for Jemperli indicated for endometrial cancer...
Apr 26

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ...
Mar 27

Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK

The agreement is for the advancement of multiple pre-phase 2 programs...
Mar 22

GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient solid cancers at ASCO Gastrointestinal Cancers Symposium

GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ...
Jan 18

ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay

...
Jan 13

Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19

Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild ...
Jan 12

GSK, MMV filing for Kozenis in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration

The application includes data for a new, 50 mg tablet that can be dispersed in water and which was developed to facilitate use in children, ...
Jan 08

Sosei Heptares collaborates with GlaxoSmithKline targeting immune disorders of the digestive system

GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform...
Dec 22

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ...
Dec 21

COVAX announces additional deals to access promising COVID-19 vaccine candidates

COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply becomes available...
Dec 19

COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021

COVAX, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating ...
Dec 19

25 Matching result(s) found!